Central and autonomic nervous systems' signs associated with in utero exposure to cocaine/opiates

H. S. Bada, Charles R Bauer, S. Shankaran, B. Lester, L. L. Wright, J. Verter, V. L. Smeriglio, L. P. Finnegan, P. L. Maza

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

In summary, we found that the prevalence of CNS/ANS signs was significantly higher in the infants exposed to cocaine and/or opiates than in nonexposed infants. However, the prevalence of a large number of these signs was less than 5%. The prevalence rates of these signs are lower when exposure involved cocaine only; thus, their assessment has limited clinical utility.

Original languageEnglish
Pages (from-to)431-434
Number of pages4
JournalAnnals of the New York Academy of Sciences
Volume846
DOIs
StatePublished - Aug 18 1998
Externally publishedYes

Fingerprint

Opiate Alkaloids
Autonomic Nervous System
Neurology
Cocaine
Central Nervous System

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Central and autonomic nervous systems' signs associated with in utero exposure to cocaine/opiates. / Bada, H. S.; Bauer, Charles R; Shankaran, S.; Lester, B.; Wright, L. L.; Verter, J.; Smeriglio, V. L.; Finnegan, L. P.; Maza, P. L.

In: Annals of the New York Academy of Sciences, Vol. 846, 18.08.1998, p. 431-434.

Research output: Contribution to journalArticle

Bada, HS, Bauer, CR, Shankaran, S, Lester, B, Wright, LL, Verter, J, Smeriglio, VL, Finnegan, LP & Maza, PL 1998, 'Central and autonomic nervous systems' signs associated with in utero exposure to cocaine/opiates', Annals of the New York Academy of Sciences, vol. 846, pp. 431-434. https://doi.org/10.1111/j.1749-6632.1998.tb09773.x
Bada, H. S. ; Bauer, Charles R ; Shankaran, S. ; Lester, B. ; Wright, L. L. ; Verter, J. ; Smeriglio, V. L. ; Finnegan, L. P. ; Maza, P. L. / Central and autonomic nervous systems' signs associated with in utero exposure to cocaine/opiates. In: Annals of the New York Academy of Sciences. 1998 ; Vol. 846. pp. 431-434.
@article{cc9b9ea67b89482ebd463295c6e38beb,
title = "Central and autonomic nervous systems' signs associated with in utero exposure to cocaine/opiates",
abstract = "In summary, we found that the prevalence of CNS/ANS signs was significantly higher in the infants exposed to cocaine and/or opiates than in nonexposed infants. However, the prevalence of a large number of these signs was less than 5{\%}. The prevalence rates of these signs are lower when exposure involved cocaine only; thus, their assessment has limited clinical utility.",
author = "Bada, {H. S.} and Bauer, {Charles R} and S. Shankaran and B. Lester and Wright, {L. L.} and J. Verter and Smeriglio, {V. L.} and Finnegan, {L. P.} and Maza, {P. L.}",
year = "1998",
month = "8",
day = "18",
doi = "10.1111/j.1749-6632.1998.tb09773.x",
language = "English",
volume = "846",
pages = "431--434",
journal = "Annals of the New York Academy of Sciences",
issn = "0077-8923",
publisher = "Wiley-Blackwell",

}

TY - JOUR

T1 - Central and autonomic nervous systems' signs associated with in utero exposure to cocaine/opiates

AU - Bada, H. S.

AU - Bauer, Charles R

AU - Shankaran, S.

AU - Lester, B.

AU - Wright, L. L.

AU - Verter, J.

AU - Smeriglio, V. L.

AU - Finnegan, L. P.

AU - Maza, P. L.

PY - 1998/8/18

Y1 - 1998/8/18

N2 - In summary, we found that the prevalence of CNS/ANS signs was significantly higher in the infants exposed to cocaine and/or opiates than in nonexposed infants. However, the prevalence of a large number of these signs was less than 5%. The prevalence rates of these signs are lower when exposure involved cocaine only; thus, their assessment has limited clinical utility.

AB - In summary, we found that the prevalence of CNS/ANS signs was significantly higher in the infants exposed to cocaine and/or opiates than in nonexposed infants. However, the prevalence of a large number of these signs was less than 5%. The prevalence rates of these signs are lower when exposure involved cocaine only; thus, their assessment has limited clinical utility.

UR - http://www.scopus.com/inward/record.url?scp=0031880428&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031880428&partnerID=8YFLogxK

U2 - 10.1111/j.1749-6632.1998.tb09773.x

DO - 10.1111/j.1749-6632.1998.tb09773.x

M3 - Article

VL - 846

SP - 431

EP - 434

JO - Annals of the New York Academy of Sciences

JF - Annals of the New York Academy of Sciences

SN - 0077-8923

ER -